相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma?
D. Landau et al.
CLINICAL ENDOCRINOLOGY (2012)
A Prospective Study of the Associations Between Treated Diabetes and Cancer Outcomes
Hsin-Chieh Yeh et al.
DIABETES CARE (2012)
Dietary conjugated linoleic acid and long-chain n-3 fatty acids in mammary and prostate cancer protection: a review
Veronica M. Heinze et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION (2012)
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Charles M. Ewing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Endocrinology of the aging male
Andre B. Araujo et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Prostate Cancer Risk in the Swedish AMORIS Study The Interplay Among Triglycerides, Total Cholesterol, and Glucose
Mieke Van Hemelrijck et al.
CANCER (2011)
Preoperative Hypogonadism Is Not an Independent Predictor of High-Risk Disease in Patients Undergoing Radical Prostatectomy
Andrea Salonia et al.
CANCER (2011)
Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
Preet K. Dhillon et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
No Association of Type 2 Diabetes Risk Variants and Prostate Cancer Risk: the Multiethnic Cohort and PAGE
Kevin M. Waters et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Obesity and Prostate Cancer Aggressiveness among African and Caucasian Americans in a Population-Based Study
L. Joseph Su et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
Mathis Grossmann et al.
CLINICAL ENDOCRINOLOGY (2011)
Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy
E. J. Hamilton et al.
CLINICAL ENDOCRINOLOGY (2011)
Management of Side Effects of Androgen Deprivation Therapy
Mathis Grossmann et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
Estrogens and Prostate Cancer: Etiology, Mediators, Prevention, and Management
Shuk-Mei Ho et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer A Meta-analysis of Randomized Trials
Paul L. Nguyen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Dihydrotestosterone Administration Does Not Increase Intraprostatic Androgen Concentrations or Alter Prostate Androgen Action in Healthy Men: A Randomized-Controlled Trial
Stephanie T. Page et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Low Testosterone in Men with Type 2 Diabetes: Significance and Treatment
Mathis Grossmann
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Zsofia Kote-Jarai et al.
NATURE GENETICS (2011)
Differing levels of testosterone and the prostate: a physiological interplay
S. Larry Goldenberg et al.
NATURE REVIEWS UROLOGY (2011)
Testosterone and modifiable risk factors associated with diabetes in men
Evan Atlantis et al.
MATURITAS (2011)
Functional Annotation of Risk Loci Identified Through Genome-Wide Association Studies for Prostate Cancer
Yizhen Lu et al.
PROSTATE (2011)
Docosahexaenoic Acid Selectively Induces Human Prostate Cancer Cell Sensitivity to Oxidative Stress Through Modulation of NF-κB
David A. Cavazos et al.
PROSTATE (2011)
Testosterone and Prostate Cancer: What are the Risks for Middle-Aged Men?
Abraham Morgentaler
UROLOGIC CLINICS OF NORTH AMERICA (2011)
Influence of obesity on the incidence and treatment of genitourinary malignancies
Suzanne Biehn Stewart et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Inhibition of NF-κB1 and NF-κB2 activation in prostate cancer cells treated with antibody against the carboxyl terminal domain of GRP78: Effect of p53 upregulation
U. K. Misra et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes
Birgitta Grundmark et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Diabetes Genes and Prostate Cancer in the Atherosclerosis Risk in Communities Study
Tamra E. Meyer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Finasteride Modifies the Relation between Serum C-Peptide and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Marian L. Neuhouser et al.
CANCER PREVENTION RESEARCH (2010)
Aberrant Activation of Fatty Acid Synthesis Suppresses Primary Cilium Formation and Distorts Tissue Development
Nicolas Willemarck et al.
CANCER RESEARCH (2010)
A 25-Year Prospective Study of Plasma Adiponectin and Leptin Concentrations and Prostate Cancer Risk and Survival
Haojie Li et al.
CLINICAL CHEMISTRY (2010)
Accuracy of calculated free testosterone formulae in men
Lam P. Ly et al.
CLINICAL ENDOCRINOLOGY (2010)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men
Torkel Vikan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells
Suying Lu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men
J. Khoo et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
Shalender Bhasin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
M. Merce Fernandez-Balsells et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Obesity and testicular function
P. M. Mah et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Massimo Ammirante et al.
NATURE (2010)
Evaluation of Association of HNF1B Variants with Diverse Cancers: Collaborative Analysis of Data from 19 Genome-Wide Association Studies
Katherine S. Elliott et al.
PLOS ONE (2010)
HNF1B and JAZF1 Genes, Diabetes, and Prostate Cancer Risk
Victoria L. Stevens et al.
PROSTATE (2010)
Testosterone and type 2 diabetes
Mathis Grossmann et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Breast and prostate cancer: more similar than different
Gail P. Risbridger et al.
NATURE REVIEWS CANCER (2010)
Association of Diabetes With Prostate Cancer Risk in the Multiethnic Cohort
Kevin M. Waters et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway
Richard M. Martin et al.
CANCER CAUSES & CONTROL (2009)
Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism
Kenji Tamura et al.
CANCER RESEARCH (2009)
Demographic, physical and lifestyle factors associated with androgen status: the Florey Adelaide Male Ageing Study (FAMAS)
Evan Atlantis et al.
CLINICAL ENDOCRINOLOGY (2009)
Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth
Abraham Morgentaler et al.
EUROPEAN UROLOGY (2009)
Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis
Mari-Anne Rowlands et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study
Jocelyn S. Kasper et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Prostate Cancer
Demetrius Albanes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Dietary n-3 polyunsaturated fatty acids enhance hormone ablation therapy in androgen-dependent prostate cancer
Michael F. McEntee et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Insulin-like growth factors, their binding proteins, and prostate cancer risk:: Analysis of individual patient data from 12 prospective studies
Andrew W. Roddam et al.
ANNALS OF INTERNAL MEDICINE (2008)
The nuclear factor-κB pathway controls the progression of prostate cancer to androgen-independent growth
Ren Jie Jin et al.
CANCER RESEARCH (2008)
Low testosterone levels are common and associated with insulin resistance in men with diabetes
Mathis Grossmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02
Matthew R. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Liver-derived IGF1 enhances the androgenic response in prostate
Johan Svensson et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
Andrew W. Roddam et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
Jing Ma et al.
LANCET ONCOLOGY (2008)
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
Eleftheria Zeggini et al.
NATURE GENETICS (2008)
Prostate tissue androgens: History and current clinical relevance
Leonard S. Marks et al.
UROLOGY (2008)
Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts
Vasundara Venkateswaran et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
Julius Gudmundsson et al.
NATURE GENETICS (2007)
Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: Correlations with bioavailable testosterone and visceral adiposity
Dheeraj Kapoor et al.
DIABETES CARE (2007)
Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort
Carmen Rodriguez et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
The metabolic syndrome is associated with reduced risk of prostate cancer
Aaron J. Tande et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism - A randomized controlled trial
Leonard S. Marks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Jocelyn S. Kasper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years
L. Lund Haheim et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Body size and composition and prostate cancer risk: systematic review and meta-regression analysis
Robert J. MacInnis et al.
CANCER CAUSES & CONTROL (2006)
Obesity, diabetes, and risk of prostate cancer: Results from the prostate cancer prevention trial
Zhihong Gong et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Effect of altering dietary ω-6/ω-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2
Naoko Kobayashi et al.
CLINICAL CANCER RESEARCH (2006)
Sex differences of endogenous sex hormones and risk of type 2 diabetes - A systematic review and meta-analysis
EL Ding et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Adiponectin as a growth inhibitor in prostate cancer cells
JD Bub et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Role of diet in prostate cancer development and progression
JM Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials
OM Calof et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2005)
Diabetes and risk of prostate cancer in a prospective cohort of US men
C Rodriguez et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Dietary n-6 and n-3 polyunsaturated fatty acids and prostate cancer risk:: a review of epidemiological and experimental evidence
P Astorg
CANCER CAUSES & CONTROL (2004)
Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis
E Bråkenhielm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes
S Dhindsa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Prostate cancer cell-adipocyte interaction -: Leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase
M Onuma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer
JC Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice
J DiGiovanni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
